Accelerating transdermal delivery of insulin by ginsenoside nanoparticles with unique permeability

• Published in: International journal of pharmaceutics 2021-08, Vol.605, p.120784-120784, Article 120784
• Main Authors: Zou, Jun-Jie, Le, Jing-Qing, Zhang, Bing-Chen, Yang, Ming-Yue, Jiang, Jia-Li, Lin, Juan-Fang, Wu, Peng-Yu, Li, Chao, Chen, Lu, Shao, Jing-Wei
• Format: Article
• Language: English
• Subjects: Ginsenoside; Insulin; Self-assembly; Sustained release; Transdermal delivery
• ISSN: 0378-5173; 1873-3476
• DOI: 10.1016/j.ijpharm.2021.120784

Insulin@Ginsenosides nanoparticles (INS@GS NPs) has long-lasting and effective transdermal effect owing to long-term, low toxicity and unique penetration ability of ginsenosides. The ginsenoside-based bilayer vesicle system provided a potential strategy of transdermal delivery of drugs like proteins and peptides that are difficult to penetrate through the skin and benefit those who are with chronic diseases that need long-term medication. [Display omitted] Diabetes is a metabolic disease caused by insufficient insulin secretion, action or resistance, in which insulin plays an irreplaceable role in the its treatment. However, traditional administration of insulin requires continuous subcutaneous injections, which is accompanied by inevitable pain, local tissue necrosis and hypoglycemia. Herein, a green and safe nanoformulation with unique permeability composed of insulin and ginsenosides is developed for transdermal delivery to reduce above-mentioned side effects. The ginsenosides are self-assembled to form shells to protect insulin from hydrolysis and improve the stability of nanoparticles. The nanoparticles can temporarily permeate into cells in 5 min and promptly excrete from the cell for deeper penetration. The insulin permeation is related to the disorder of stratum corneum lipids caused by ginsenosides. The skin acting as drug depot mantains the nanoparticles released continuously, therefore the body keeps euglycemic for 48 h. Encouraged by its long-lasting and effective transdermal therapy, ginsenosides-based nano-system is expected to deliver other less permeable drugs like proteins and peptides and benefit those who are with chronic diseases that need long-term medication.